- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT02550990
Synergistic Effects of Aerobic Exercise and Cognitive Training on Cognition in Stroke Patients With Cognitive Decline
Synergistic Effects of Aerobic Exercise and Cognitive Training on Cognition, Physiological Markers, Daily Function and Quality of Life in Stroke Patients With Cognitive Decline
Descripción general del estudio
Estado
Tipo de estudio
Inscripción (Anticipado)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
-
Chiayi City, Taiwán, 613
- Reclutamiento
- Chiayi Chang Gung Memorial Hospital
-
Contacto:
- Shi-Zhe Lin, MS
- Número de teléfono: 2688 +886-5-3621000
- Correo electrónico: apirlline@cgmh.org.tw
-
Kaohsiung City, Taiwán, 83301
- Reclutamiento
- Kaohsiung Chang Gung Memorial Hospital
-
Contacto:
- Ku-Chou Chang, MD
- Número de teléfono: 2285 +886-7317123
- Correo electrónico: kcchang@cgmh.org.tw
-
Keelung City, Taiwán, 204
- Reclutamiento
- Keeling Chang Gung Memorial Hospital
-
Contacto:
- Chia-Ling Chen, PhD
- Número de teléfono: 8147 +886-3-3281200
- Correo electrónico: ccl1374@adm.cgmh.com.tw
-
Taipei City, Taiwán, 105
- Reclutamiento
- Taipei Chang Gung Memorial Hospital
-
Contacto:
- Chia-Ling Chen, PhD
- Número de teléfono: 8147 +886-3-3281200
- Correo electrónico: ccl1374@adm.cgmh.com.tw
-
Taoyuan City, Taiwán, 333
- Reclutamiento
- Taoyuan Chang Gung Memorial Hospital
-
Contacto:
- Chia-Ling Chen, PhD
- Número de teléfono: 8147 +886-3-3281200
- Correo electrónico: ccl1374@adm.cgmh.com.tw
-
-
Taoyuan
-
Kwei-Shan, Taoyuan, Taiwán, 333
- Reclutamiento
- Chang Gung Memorial Hospital
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Ischemic or hemorrhagic stroke occurring at least 6 months prior to enrollment
- Age range from 20 to 90 years
- MMSE score ≥ 19
- MoCA<26
- Self- or informant-reported memory or cognitive complaints or CDR scale ≤ 0.5
- Able to follow the study instruction
- Adequate cardiopulmonary function to perform aerobic exercise
- Able to walk with or without assistive devices
Exclusion Criteria:
- Unstable medical history (e.g., recent myocardial infarction) that might limit participation
- Concomitant with other neurological disorders (e.g., Parkinson's disease, amyotrophic lateral sclerosis, multiple sclerosis)
- Current participation in another interventional trial
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Único
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Comparador activo: Cognitive training group
One 60-min session of cognitive training.
Before and after the treatment, a total of 2 evaluations were conducted, including clinical assessments and blood test (each 18c.c.).
A saliva sample (2 mL) will only be collected once from each subject.
A follow-up assessment of clinical outcomes will be conducted at six month after the end of the course of treatment.
|
|
|
Comparador activo: Aerobic exercise training group
One 60-min session of aerobic exercise training.
Before and after the treatment, a total of 2 evaluations were conducted, including clinical assessments and blood test (each 18c.c.).
A saliva sample (2 mL) will only be collected once from each subject.
A follow-up assessment of clinical outcomes will be conducted at six month after the end of the course of treatment.
|
|
|
Experimental: Sequential training group
One 30-min session of aerobic exercise training + one 30-min session of cognitive training. Before and after the treatment, a total of 2 evaluations were conducted, including clinical assessments and blood test (each 18c.c.). A saliva sample (2 mL) will only be collected once from each subject. A follow-up assessment of clinical outcomes will be conducted at six month after the end of the course of treatment. |
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change scores of Montreal Cognitive Assessment (MoCA)
Periodo de tiempo: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
|
|
Change scores of Wechsler Memory Scale - Third Edition (WMS-III)
Periodo de tiempo: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
|
|
Change scores of Wechsler Adult Intelligence Scale - Third Edition (WAIS-III)
Periodo de tiempo: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
|
|
Change scores of Useful Field of View (UFOV)
Periodo de tiempo: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
|
|
Change scores of Stroop Color-Word test
Periodo de tiempo: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
|
|
Change scores of Dual-task test
Periodo de tiempo: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
The dual-task tests will be assessed to determine the ability for an individual to perform 2 tasks simultaneously.
The investigators will assess the dual-task performance during walking and performing box and block test.
The results of the dual-task tests will provide information regarding to whether the 2 tasks compete for the same class of neural resources or one of the tasks can be carried out automatically.
|
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Cambiar las puntuaciones del marcador antioxidante
Periodo de tiempo: Línea de base, prueba posterior (un promedio esperado de 3 meses)
|
Se utilizarán marcadores antioxidantes para reflejar los cambios en el estrés oxidativo.
En particular, estaremos analizando la capacidad antioxidante total (TAC).
|
Línea de base, prueba posterior (un promedio esperado de 3 meses)
|
|
Cambiar las puntuaciones del nivel de lípidos en plasma
Periodo de tiempo: Línea de base, prueba posterior (un promedio esperado de 3 meses)
|
Se evaluará la proporción de colesterol (colesterol total dividido por lípidos de alta densidad) para reflejar el nivel de lípidos en la sangre.
|
Línea de base, prueba posterior (un promedio esperado de 3 meses)
|
|
Change scores of serum BDNF level
Periodo de tiempo: Baseline, posttest (an expected average of 3 months)
|
Baseline, posttest (an expected average of 3 months)
|
|
|
Change scores of Glucose indicator
Periodo de tiempo: Baseline, posttest (an expected average of 3 months)
|
HbA1C level will be tested to investigate the relationships between blood glucose level and aerobic exercise.
|
Baseline, posttest (an expected average of 3 months)
|
|
Change scores of Functional Independence Measure (FIM)
Periodo de tiempo: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
|
|
Change scores of Lawton Instrumental Activities of Daily Living Scale (Lawton IADL)
Periodo de tiempo: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
|
|
Change scores of Stroke Impact Scale (SIS)
Periodo de tiempo: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
|
|
Change scores of Caregiver Burden (CB) scale
Periodo de tiempo: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
|
|
Change scores of EuroQol (EQ)-5D questionnaire
Periodo de tiempo: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
|
|
Change scores of Timed up and go test (TUG)
Periodo de tiempo: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
|
|
Change scores of Six-minute walk test (6MWT)
Periodo de tiempo: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
|
|
Change scores of Mobility level
Periodo de tiempo: Baseline, posttest (an expected average of 3 months)
|
Baseline, posttest (an expected average of 3 months)
|
|
|
Change scores of International Physical Activity Questionnaires (IPAQ)
Periodo de tiempo: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
|
|
Change scores of Fugl-Meyer Assessment (FMA)
Periodo de tiempo: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
|
|
Change scores of Rivermead Mobility Index (RMI)
Periodo de tiempo: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
|
|
Change scores of muscle strength
Periodo de tiempo: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
We will evaluate isometric knee flexors and extensors muscle strength using handheld dynamometer.
Also, we will use hand dynamometer to measure grip strength of the affected and less affected hand while the participant is seated, with the elbow at 90-degree flexion.
We will record the mean value of 3 attempts.
|
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
|
Change scores of Community Integration Questionnaire (CIQ)
Periodo de tiempo: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
|
|
Change scores of Geriatric Depression Scale (GDS)
Periodo de tiempo: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
|
|
|
Genotyping of the BDNF val66met polymorphism
Periodo de tiempo: Between baseline and posttest (an expected average of 3 months)
|
Between baseline and posttest (an expected average of 3 months)
|
Colaboradores e Investigadores
Patrocinador
Publicaciones y enlaces útiles
Publicaciones Generales
- Gibson E, Koh CL, Eames S, Bennett S, Scott AM, Hoffmann TC. Occupational therapy for cognitive impairment in stroke patients. Cochrane Database Syst Rev. 2022 Mar 29;3(3):CD006430. doi: 10.1002/14651858.CD006430.pub3.
- Yeh TT, Wu CY, Hsieh YW, Chang KC, Lee LC, Hung JW, Lin KC, Teng CH, Liao YH. Synergistic effects of aerobic exercise and cognitive training on cognition, physiological markers, daily function, and quality of life in stroke survivors with cognitive decline: study protocol for a randomized controlled trial. Trials. 2017 Aug 31;18(1):405. doi: 10.1186/s13063-017-2153-7.
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio
Finalización primaria (Anticipado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Estimar)
Actualizaciones de registros de estudio
Última actualización publicada (Estimar)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- 104-4892A3
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .